New research shows a common over-the-counter drug may have significant benefits for people with colon and rectal cancer.

A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study ...

New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria ...

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new Karolinska ...

A daily low dose of aspirin could sharply cut the risk of colorectal cancer returning after surgery, according to a large ...

Daily aspirin can cut in half the risk that colon cancer will come back. Risk of recurrence was 55% lower in people who took ...

A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...

A groundbreaking new clinical trial has found that taking a low dose of the common fever medicine Aspirin halves the risk of gut cancer recurrence after tumour surgery.

Please provide your email address to receive an email when new articles are posted on . Low-dose methotrexate did not relieve pain or reduce synovitis in inflammatory knee OA. The findings do not ...

Aspire’s sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes ...